'Foul' BioVentrix Cash-Out Gets Extra Scrutiny, Chancery Says

By Leslie A. Pappas · May 1, 2024, 6:41 PM EDT

A medical device company's decision to suddenly and without explanation cash out its common stockholders for less than a penny just two months before the company raised $48.5 million in new...

To view the full article, register now.